To explore whether IFI6 plays a role in breast cancer cell growth downstream of UBE2T, we first examined whether IFI6 is overexpressed in patient-derived breast cancer samples compared with normal breast tissues, similar to UBE2T overexpression. Here, UBE2T is linked to breast carcinoma.